2024 annual financial data
Polaryx Therapeutics 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -4,352,000 USD and net income was -30,356,000 USD.
Operating cash flow was -2,573,000 USD.
Get free Polaryx Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,352,000 USD
- Net income
- -30,356,000 USD
- Operating cash flow
- -2,573,000 USD